Literature DB >> 26571129

Function from within: Autophagy induction by HPSE/heparanase--new possibilities for intervention.

Neta Ilan1, Anna Shteingauz1, Israel Vlodavsky1.   

Abstract

HPSE (heparanase) is the predominant enzyme in mammals capable of cleaving heparan sulfate, an activity highly implicated in cellular invasion and tumor metastasis. HPSE expression is induced in many types of cancer and increased HPSE levels are most often associated with increased tumor metastasis and reduced patient survival post operation. In addition, HPSE induction is associated with progression of the primary tumors but the mechanism(s) underlying tumor expansion by HPSE have not been sufficiently resolved. Our results establish a role for heparanase in modulating autophagy in normal and malignant cells, thereby conferring growth advantages as well as resistance to chemotherapy.

Entities:  

Keywords:  MTORC1; autophagy; chemoresistance; heparanase; p70 S6-kinase; tumor growth

Mesh:

Substances:

Year:  2015        PMID: 26571129      PMCID: PMC4835213          DOI: 10.1080/15548627.2015.1115174

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  12 in total

Review 1.  Heparanase: From basic research to therapeutic applications in cancer and inflammation.

Authors:  Israel Vlodavsky; Preeti Singh; Ilanit Boyango; Lilach Gutter-Kapon; Michael Elkin; Ralph D Sanderson; Neta Ilan
Journal:  Drug Resist Updat       Date:  2016-10-06       Impact factor: 18.500

2.  Heparanase Expression Propagates Liver Damage in CCL4-Induced Mouse Model.

Authors:  Xiaowen Cheng; Juan Jia; Tianji Zhang; Xiao Zhang; Israel Vlodavsky; Jin-Ping Li
Journal:  Cells       Date:  2022-06-27       Impact factor: 7.666

Review 3.  Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.

Authors:  Ralph D Sanderson; Michael Elkin; Alan C Rapraeger; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2016-11-16       Impact factor: 5.542

Review 4.  Mechanisms of heparanase inhibitors in cancer therapy.

Authors:  Benjamin Heyman; Yiping Yang
Journal:  Exp Hematol       Date:  2016-08-26       Impact factor: 3.084

Review 5.  Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression.

Authors:  Israel Vlodavsky; Miriam Gross-Cohen; Marina Weissmann; Neta Ilan; Ralph D Sanderson
Journal:  Trends Biochem Sci       Date:  2017-11-20       Impact factor: 13.807

Review 6.  Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity.

Authors:  Cinzia Lanzi; Giuliana Cassinelli
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

Review 7.  Heparan Sulfate Glycosaminoglycans: (Un)Expected Allies in Cancer Clinical Management.

Authors:  Isabel Faria-Ramos; Juliana Poças; Catarina Marques; João Santos-Antunes; Guilherme Macedo; Celso A Reis; Ana Magalhães
Journal:  Biomolecules       Date:  2021-01-21

8.  Heparanase attenuates axon degeneration following sciatic nerve transection.

Authors:  Michael J Whitehead; Rhona McGonigal; Hugh J Willison; Susan C Barnett
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

Review 9.  The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives.

Authors:  Noemi Veraldi; Nawel Zouggari; Ariane de Agostini
Journal:  Molecules       Date:  2020-01-17       Impact factor: 4.411

10.  Heparan Sulfate Structure Affects Autophagy, Lifespan, Responses to Oxidative Stress, and Cell Degeneration in Drosophila parkin Mutants.

Authors:  Claire Reynolds-Peterson; Jie Xu; Na Zhao; Casey Cruse; Brandon Yonel; Claire Trasorras; Hidenao Toyoda; Akiko Kinoshita-Toyoda; Jennifer Dobson; Nicholas Schultheis; Mei Jiang; Scott Selleck
Journal:  G3 (Bethesda)       Date:  2020-01-07       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.